期刊文献+

肿瘤标志物对癌性胸腔积液诊断的价值 被引量:2

Diagnosis Value of Tumor Markers for Malignant Pleural Effusions
在线阅读 下载PDF
导出
摘要 目的探讨肿瘤标志物在癌性胸腔积液诊断中的价值。方法应用免疫放射分析法对108例癌性胸腔积液和90例良性胸腔积液的CYFRA21-1、CEA、NSE和CA153含量进行检测,并对结果进行比较分析。结果癌性胸腔积液中四种肿瘤标志物指标明显高于良性组(P<0.01),四项联检后的敏感性、特异性及准确性明显升高。结论肿瘤标志物CYFRA21-1、CEA、NSE和CA153四项联检在癌性胸腔积液的诊断中具有明确的意义。 Objective To investigate the diagnosis value of tumor markers(CYFRA21-1,CEA,NSE and CA153) in malignant pleural effusions.Methods 108 cases with malignant pleural effusions and 90 cases with benign pleural effusions were detected by radio immunoassay and ELISA,and then the results were compared.Results The four item of cancerous pleural effusion group were markedly higher than those of the benign ones(P0.01).The sensitivity,specificity and accuracy rating of the combined detection of targets for diagnostician malignant pleural effusion were markedly higher.Conclusion The combined detection of CYFRA21-1,CEA,NSE and CA153 has specific value in the diagnosis for malignant pleural effusions.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第4期434-436,共3页 Cancer Research on Prevention and Treatment
关键词 肿瘤标志物 癌性胸腔积液 诊断 Tumor markers Malignant pleural effusions Diagnosis
  • 相关文献

参考文献14

  • 1Pavesi F, Lotzniker M, Cremaschi P, et al.Detection of malignant pleural effusions by tumor marker evalution [J].Eur J Cancer Clin Oncol, 1988,24(6):1005-1011.
  • 2Ando S,Kimura H,Iwai N,et al.Optimal combination of seven tumor markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer [J].Anticancer Res,2001,21(4B):3085-3092.
  • 3Kulpa J,Wojcik E,Reinfuss M,et al.Carcinoembryonic antigen,squamous cell carcinoma antigen,CYFRA21-1,and neuron-specific enolase in squamous cell lung cancer patients [J].Clin Chem,2002,48(11):1931-1937.
  • 4应海平.胸水ADA和CEA检测在胸腔积液中的鉴别诊断价值[J].现代实用医学,2006,18(6):390-390. 被引量:17
  • 5Shitrit D, Zingerman B,Shlomi D,et al.Diagnostic value of CYFRA 21-1,CEA,CA199,CA15-3 and CA125 assays in pleural effusions: analysis of 116 cases and review of the literature [J].Oncologist,2005,10(7):501-507.
  • 6劳明,潘弘,张其进,黄文成,韦礼斌,朱波.血清CEA、Pro-GRP、CYFRA21-1及β_2-MG联合检测在肺癌诊断中的意义[J].实用医学杂志,2005,21(22):2574-2577. 被引量:9
  • 7Broers JL, Ramaekers FC,Rot MK,et al.Cytokeratins in different types of human lung cancer as monitored by chain specific monoclonal antibodies[J].Cancer Res,1998,48(11): 3221-3229.
  • 8Toumbis M, Rasidakis A, Passalidou E, et al.Evaluation of CYFRA21-1 in malignant and benign pleural effusions[J].Anticancer Res,1996,16(4A):2101-2104.
  • 9刘运秋,林江涛.ProGRP及CYFRA21-1检测对胸腔积液鉴别诊断的价值[J].中华全科医师杂志,2006,5(7):408-411. 被引量:5
  • 10王英,黄玲莎,黄文成.三种血清肿瘤标志物在肺癌诊断中的临床价值[J].医学临床研究,2006,23(5):661-662. 被引量:13

二级参考文献27

  • 1徐丽艳,游泳红,朱允中,刘哲.检测SCLC患者血清胃泌素释放肽前体和神经特异性烯醇化酶的临床意义[J].中国肺癌杂志,2004,7(4):367-369. 被引量:4
  • 2肖拥军,易芬贤,孙延亮,唐伟建.血清C_(A125)、C_(A153)、C_(A242)三种肿瘤标志物联合检测对肺癌诊断的价值[J].现代肿瘤医学,2005,13(2):200-201. 被引量:14
  • 3Yamaguchi K, Abe K, Kameya T, et al. Production and molecular size heterogeneity of immunoreaetive gastfin-releasing peptlde in fetal and adult lungs and primary lung tumors. Cancer Res, 1983, 43(8):3932 - 3939.
  • 4Oremek GM, Sapoutzis N. Pro-gastrin-releasing peptide(Pro-GRP), a tumor marker for small cell lung cancer. Anticancer Res, 2003,23(2A) :895 - 898.
  • 5Niho S, Nishiwaki Y, Goto K, et al. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen . Lung Cancer, 2000,27 (3) : 159 - 167.
  • 6Tas F, Aydiner A, Topuz E, et al. Utility of the serum tumor marker:CYFRA21-1, CEA, SCC in squamous cell lung cancer . J Exp Clin Cancer Rs,2000,19(4) :477 - 481.
  • 7查人俊.肺癌患者血清B,徽球蛋白和癌胚抗原测定及其临床意义[J].中华肿瘤杂志,1986,8(5):342-345.
  • 8Miedouge M,Devys A,Simon M,et al.High levels of cytokeratin 19 fragments but no evidence of cytokeratins 1,2,10/11,14 or filaggrin in the serum of squamous cell lung carcinoma patients[J].Tumor Biol,2001,22:19-26.
  • 9Nakata B,Chung YS,Kato Y,et al.Clinical significance of serum CYFRA21-1 in gastric cancer[J].Br J Cancer,1996,73(12):1529-1532.
  • 10Shijubo N,Hirasawa M,Sasaki H,et al.Elevated progastrinreleasing peptide (31-98) concent-rations in hydrothoraxs to small-cell Lung Carcinoma.Respiration,1996,63:106.

共引文献58

同被引文献23

  • 1赵惠柳,黄文成.肿瘤标记物CYFRA21-1的临床应用新进展[J].现代肿瘤医学,2005,13(1):129-131. 被引量:4
  • 2蒋联萍,赵玉萍.鳞状上皮细胞癌抗原SCC-Ag监测宫颈鳞癌的临床意义[J].江西医药,2006,41(11):853-855. 被引量:10
  • 3Mucke R, Ziegler PG, Libera T, et al. The muhimodality therapy of advanced inoperable esophageal carcinoma. Aretrospective analysis[J].Strahlenther 0ncol,2000,176 (8): 350.
  • 4Snykers S, De Kock J, Vanhaecke T, et al. Differentiation of neonatal rat epithelial cells from biliary origin into immature hepatic cells by sequential exposure to hepatogenic eytokines and growth factors reflecting liver development[J].Toxicol In Vitro,2007,21 (7): 1325- 1331.
  • 5Dohmoto K, Hojo S, Fujita J, et al. M echan ism s of therelease of CYFRA21-1 in hum an lung cancer cell 1 ines[J]. Lung Cancer, 2000,30 ( 1 ) : 55-63.
  • 6Sheard MA, Vojtesek B, Simickova M, et al.Release of cytok erat in-18 and -19 fragm ents ( TPS and CYFRA 21-1 ) into the extracellu lar space during apop tos is[J].J Cell Biochem, 2002,85 ( 4 ) : 670-677.
  • 7Saloustros E, Mavroudis D. Cytokeratin 19-positive circulating tumor cells in early breast cancer prognosis[J]. Future Oncol,2010,6 ( 2 ) : 209-219.
  • 8Schmitt AC, Cohen C, Siddiqui MT.Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needie aspiration of papillary thyroid carcinoma: diagnostic utility[J].Cancer Cytopathol,2010,118 ( 4 ) : 196-202.
  • 9Uenishi T, Yamazaki O, Yamamoto T, et al.Clinical significance of serum cytokerat in-19 fragment ( CYFRA 21-1 ) in hepatocellular careinoma[J].J Hepato-biliary- pancreatic Surg,2006, 13 ( 3 ) : 239-244.
  • 10Uenishi T, Kubo S, Hirohashi K, et al.C ytokerat in- 19 fragments in serum ( CYFRA 21-1 ) asamarker in primary liver cancer[J].Br J Cancer,2003,88 ( 12 ) 1894-1899.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部